Literature DB >> 7468887

The advent of human diploid cell rabies vaccine: impact on vaccine utilization in New Mexico.

J M Mann, R E Hoffman, O J Rollag, L Bartol, M J Burkhart.   

Abstract

Three months' experience with the newly licensed human diploid cell rabies vaccine in the New Mexico comprehensive consultation-biologics system was reviewed. Comparison with the same period in 1978 and 1979 showed no increase in vaccine utilization despite the advent of this simpler-to-use, safer rabies vaccine. Anti-rabies treatments appear to be minimally influenced by new vaccine technology when a comprehensive consultation system is available to support and guide the private physician.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7468887      PMCID： PMC1619679          DOI： 10.2105/ajph.71.4.423

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  4 in total

1.  Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum.

Authors:  M Bahmanyar; A Fayaz; S Nour-Salehi; M Mohammadi; H Koprowski
Journal:  JAMA       Date:  1976-12-13       Impact factor: 56.272

2.  Adverse reactions to duck embryo rabies vaccine. Range and incidence.

Authors:  R H Rubin; M A Hattwick; S Jones; M B Gregg; V D Schwartz
Journal:  Ann Intern Med       Date:  1973-05       Impact factor: 25.391

3.  Anti-rabies treatments in New Mexico: impact of a comprehensive consultation-biologics system.

Authors:  J M Mann; M J Burkhart; O J Rollag
Journal:  Am J Public Health       Date:  1980-02       Impact factor: 9.308

4.  Postexposure trial of a human diploid cell strain rabies vaccine.

Authors:  L J Anderson; R K Sikes; C W Langkop; J M Mann; J S Smith; W G Winkler; M W Deitch
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.